Leukemia - Acute Leukemia Panel, Bone Marrow Test

The Leukemia panel consists of morphological examination of EDTA and heparin bone marrow and flow cytometric analysis of Lymphoid T cells, Lymphoid B cells, Myeloid and Monocytic cells.

• In case of abnormalities detected in the routine blood examination (CBC) along with other investigations, the Leukemia panel may be useful for further diagnosis.
• The test is done in patients in whom leukemia or lymphoma is suspected.
• To find out the type of leukemia or lymphoma
• This panel aids proper diagnosis, helps in choosing the right treatment line and monitoring of the patient.

Morphological examination of bone marrow for Differential count, blasts, neutrophils, lymphocytes, eosinophils percentage, RBC structure and platelets examination is done.

The leukemia cells may continue to multiply and develop into Lymphoid T cells, Lymphoid B cells, Myeloid and Monocytic cells.

Leukemia may often be asymptomatic in the early stages. People with following clinical signs should however, undergo the test:

• Fatigue, easy tiredness
• Unexplained weight loss
• Frequent infections, fever
• Bone or joint pain and tenderness
• Easy bleeding or bruising with red spots or purplish discoloration.

This test requires bone marrow sample along with whole blood smear. A small incision is made on the skin, and a hollow needle is inserted from the bone up to the bone marrow to collect the bone marrow sample. The skin is disinfected before needle insertion and the sample is collected in vacutainer.

Medical history / Heamato-pathological reports is required.

The immunophenotyping of leukemic cells in the bone marrow shows differential count of various blood cells.

Based on the differential count percentage, diagnosis of leukemia and its type can be made.

The positivity percentage of Lymphoid T cells, Lymphoid B cells, Myeloid cells and Monocytic cells is further indicative of the Leukemia diagnosis and its respective classification.eg. B - Cell Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia.

• Leukemia Test
• Bone marrow examination test
• Flow cytometry test

Acute Leukaemia Panel test is a comprehensive diagnostic test combines morphological examination of blood smears and flow cytometric analysis to detect and classify acute leukaemia, a type of blood cancer characterised by the abnormal growth and mutation of white blood cells.

Yes, home sample collection is available for the Leukaemia test. A trained phlebotomist can collect blood samples at your home.

The Leukaemia test is used to diagnose and classify acute leukaemia, determine the appropriate treatment plan, and monitor the patient's condition. It helps healthcare providers make informed decisions about the management of blood cancer.

There is no "normal range" for the Leukaemia test as it is a diagnostic test. The presence and type of abnormal cells indicate the diagnosis of leukaemia, and the results are interpreted by qualified healthcare professionals.

Patients suspected of having leukaemia or lymphoma, those with symptoms indicative of leukaemia (such as fatigue, unexplained weight loss, frequent infections, and easy bleeding or bruising), and those with abnormalities in routine blood examinations are eligible for the Acute Leukaemia Panel test.

The benefits of the Leukaemia test include accurate diagnosis, classification of leukaemia, guidance for treatment planning, and monitoring of the disease. It helps healthcare providers make informed decisions and tailor treatment plans to the specific type of leukaemia.

The testing frequency for the Leukaemia test is determined by the healthcare provider based on the patient's condition and treatment plan. It may be done at regular intervals to monitor the progress of the disease and the effectiveness of treatment.

There is no specific time requirement for the Leukaemia test; it can be done at any time as per the healthcare provider's schedule. The test is typically performed when symptoms or abnormalities in routine blood tests suggest the possibility of leukaemia.

Generally, no fasting is required for Leukaemia test. However, it is always best to follow the specific instructions provided by your healthcare provider or the diagnostic laboratory.

Patients should provide a complete medical history and any relevant hematopathological reports to their healthcare provider. No other specific precautions are typically necessary before undergoing the Leukaemia test.

The Leukaemia test includes morphological examination of blood smears and flow cytometric analysis of Lymphoid T cells, Lymphoid B cells, Myeloid cells, and Monocytic cells. These parameters help in the accurate diagnosis and classification of acute leukaemia.

The Leukaemia test involves collecting a blood sample, performing a morphological examination of the blood smear, and conducting flow cytometric analysis. The blood sample is typically drawn from a vein in the arm, and the analysis is performed in a specialised laboratory.

The Leukaemia test should be done when symptoms suggestive of leukaemia are present, such as fatigue, unexplained weight loss, frequent infections, and easy bleeding or bruising. It may also be recommended when abnormalities are detected in routine blood examinations.

The Leukaemia test becomes positive when it detects the presence of leukaemic cells and specific markers indicative of acute leukaemia. The test results are interpreted by qualified healthcare professionals to determine the specific type of leukaemia.

The actual test procedure for the Leukaemia test is quick, and it may only take about 2 to 10 minutes for the blood sample collection.

The reports for the Leukaemia test are usually available within 24 hours, depending on the lab's turnaround time. Your healthcare provider will inform you about the expected timeline for receiving the results.